Kuo Kang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kuo Kang has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Changhao Huang
Hunan Key Laboratory of Precise Diagnosis and Treatment of Gastrointestinal Tumor, Xiangya Hospital Central South University , Changsha , Hunan , China
1 shared publication - Linfeng Wei
Department of General Surgery , The Second Xiangya Hospital Central South University , Changsha , Hunan , China
1 shared publication - Shalong Wang
Department of General Surgery, The Second Xiangya Hospital of Central South University
1 shared publication - Xuanxuan Li
Department of Oncology , Xiangya Hospital, Central South University , Changsha , Hunan , China
1 shared publication - Zhiwei Wu
Department of Organ Transplant Center, Xiangya Hospital of Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 21 (1)
The causal role of plasma protein ratios in ulcerative colitis: insights from mendelian randomization and single-cell sequencing
Objectives: This Mendelian randomization study aimed to systematically investigate the causal associations of 2,821 plasma protein ratios with UC susceptibility and validate potential biomarkers through multi-omics approaches. Methods: This study employed a two-sample Mendelian randomization (MR) approach using publicly available genetic data from genome-wide association studies (GWAS), with single nucleotide polymorphisms (SNPs) serving as instruments for exposures and outcome variables. Using the two-sample MR approach, we assessed the associations between 2,821 plasma protein ratios and UC and performed a series of sensitivity analyses to enhance the robustness of our findings. Additionally, single-cell sequencing was used to validate and explore the MR results. And ELISA assays were carried to validate the expression of certain protein ratios. Results: The inverse-variance weighted method identified significant relationships between 165 plasma protein ratios and UC (FDR<0.05). UC susceptibility, per one standard deviation increase in genetically predicted protein ratios, ranged from 0.539 (DCTN1/IKBKG, 95 % CI: 0.408–0.712) to 2.078 (CCT5/DCTN1, 95 % CI: 1.607–2.686). Various sensitivity analyses further confirmed the robustness of these causal relationships. Single-cell sequencing further revealed significant differences in DLL1/TGFBR2 ratios between UC and healthy controls (p<0.0001), with a moderate yet significant elevation in CCT5/DCTN1 ratios (p<0.01) and no notable difference in BCR/DCTN1 ratios. Validation using ELISA in 26 pairs of UC patients and healthy controls showed a significantly elevated DLL1/TGFBR2 ratio in the UC group (p<0.001), while CCT5/DCTN1 and BCR/DCTN1 ratios showed no differences. Conclusions: The findings reveal a robust causal relationship between the DLL1/TGFBR2 plasma protein ratio and UC, offering novel insights into the diagnosis and treatment of the disease.
- 1 January 2026
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 21 (1)
Open AccessThe causal role of plasma protein ratios in ulcerative colitis: insights from mendelian randomization and single-cell sequencing
Objectives: This Mendelian randomization study aimed to systematically investigate the causal associations of 2,821 plasma protein ratios with UC susceptibility and validate potential biomarkers through multi-omics approaches. Methods: This study employed a two-sample Mendelian randomization (MR) approach using publicly available genetic data from genome-wide association studies (GWAS), with single nucleotide polymorphisms (SNPs) serving as instruments for exposures and outcome variables. Using the two-sample MR approach, we assessed the associations between 2,821 plasma protein ratios and UC and performed a series of sensitivity analyses to enhance the robustness of our findings. Additionally, single-cell sequencing was used to validate and explore the MR results. And ELISA assays were carried to validate the expression of certain protein ratios. Results: The inverse-variance weighted method identified significant relationships between 165 plasma protein ratios and UC (FDR<0.05). UC susceptibility, per one standard deviation increase in genetically predicted protein ratios, ranged from 0.539 (DCTN1/IKBKG, 95 % CI: 0.408–0.712) to 2.078 (CCT5/DCTN1, 95 % CI: 1.607–2.686). Various sensitivity analyses further confirmed the robustness of these causal relationships. Single-cell sequencing further revealed significant differences in DLL1/TGFBR2 ratios between UC and healthy controls (p<0.0001), with a moderate yet significant elevation in CCT5/DCTN1 ratios (p<0.01) and no notable difference in BCR/DCTN1 ratios. Validation using ELISA in 26 pairs of UC patients and healthy controls showed a significantly elevated DLL1/TGFBR2 ratio in the UC group (p<0.001), while CCT5/DCTN1 and BCR/DCTN1 ratios showed no differences. Conclusions: The findings reveal a robust causal relationship between the DLL1/TGFBR2 plasma protein ratio and UC, offering novel insights into the diagnosis and treatment of the disease.